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In this study, prevention of the adhesion bands and inflammatory features has been investi-
gated using poly (lactic-co-glycolic acid)-ibuprofen (PLGA-IB) nanofibrous meshes in a
mice model. To find the optimized membrane for prevention of postoperative adhesion bands,
we have compared PLGA-IB group with PLGA, IB, and control groups in a mice adhesion
model. Two scoring adhesion systems were used to represent the outcome. According to the
results obtained in this study, the PLGA-IB nanofiber membrane showed a greater reduction
in adhesion band than other groups. In conclusion, among FDA-approved polymers and
drugs, PLGA-IB meshes could be applicable as a potential candidate for prevention of post-
operative abdominal inflammation and adhesion bands formation. VC 2016 American Institute
of Chemical Engineers Biotechnol. Prog., 32:990–997, 2016
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Introduction
Wound healing is a complex process in which a series of
cellular and humoral components interact to re-epithelialize a
wound defect.1 Peritoneal adhesions are a worldwide problem
and may occur following any type of abdominal or pelvic sur-
gery. They are fibrous bands that form between tissues and
organs. These bands are the consequence of inflammatory
reactions after damage to the peritoneum and have been well
recognized as an important part of the wound healing pro-
cess.2 Invasive surgery is typically accompanied by a number
of clinical problems, induced or exacerbated by adhesion
bands, including female infertility, bowel obstruction, and dif-
ficult reoperative procedures. Adhesion bands have often been
reported in clinical patients with foreign body reaction/infec-
tion, trauma, ischemia, and hemorrhage.2–6
The hope now is to identify agents that would efficiently
reduce the formation of adhesion in various surgical proce-
dures without inducing side effects. In moving toward this
goal, different strategies such as various surgical techniques,
surgical adjuvants for example fibrinolytic agents, anticoagu-
lants, anti-inflammatory agents, antibiotics, different barriers
and mechanical separation have been tested to prevent or at
least diminish the high incidence of adhesions in patients.4
Among these strategies, it seems physical barriers are one of
the most accepted methods for prevention of adhesion
formation.7
An antiadhesive barrier not only should have appropriate
mechanical properties to facilitate handling and manipulation
but also needs to possess suitable biomaterial surface hydro-
philicity from the point of view of surface chemistry. A
reduced amount of cell attachment is often seen on surfaces
with a high hydrophilic nature.8,9
Previous finding have provided evidence that synthetic
polymeric materials are preferable to natural agents in this
context, mainly due to their ease of handling and lower level
of immunogenicity. The principal objective of using syn-
thetic barriers is to prevent mechanical contact between tis-
sues around the damaged site to reduce these bands during
the important period of peritoneal repair and healing. By
reducing the formation of a fibrin matrix between serosal
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surfaces and implanted materials, synthetic barriers act to
prevent the formation of adhesion bands.10
Electrospun fibers have found applications in tissue engi-
neering, biomolecule immobilization, nutraceutical delivery,
biosensing, bioremediation, and in the development of anti-
microbial mats and etc.11–13
Recently, electrospun nanofibrous membranes have
emerged as hopeful antiadhesion barriers. Electrospun
membranes have attracted the interest of research for some
time because of their bulk semi conductivity and, in some
cases, one-dimensional ohmic conductivity. Electrospinning
is a process by which fabricated polymeric membranes can
be produced with nanofibrous structure in a simple, versa-
tile, and economical manner. The application of electrospun
nanofibrous membranes in preventing adhesion bands was
described for the first time by Zong et al.14 Thereafter, sev-
eral applications of this membrane have been reported in
the field of tissue engineering and regenerative medicine.
For instance, the polycaprolactone (PCL) electrospun mem-
branes have been effectively used in reduction of postoper-
ative adhesions in a study conducted by Chen et al.15,16 In
view of the above findings, in the current study investigated
the antiadhesive and anti-inflammatory effects of electro-
spun nanofibrous membranes made of PCL, poly-L-lactide
(PLLA), poly(lactic-co-glycolic acid) (PLGA), and polye-
thersulfune (PES) in comparison with the oxidized-
regenerated cellulose (Interceed) that has been approved by
FDA for clinical use. Our results revealed that compared
with other membranes, PCL, PLGA, and Interceed mem-
branes showed a greater ability to reduce adhesions. More-
over, PLGA nanofibrous membranes showed the lowest
level of both cell attachment in vitro and inflammation in
adhesive tissues.9
Given that inflammation is a primitive protective response
following surgical operation, determining ways of decreasing
inflammation is of great interest. Ibuprofen (IB) is introduced
as a nonsteroidal anti-inflammatory drug and is used to
reduce fever and treat pain or inflammation caused by many
conditions.7,10 In this regard, Hu et al.7 showed that PLLA
containing IB improves anti-inflammatory activity in the pre-
vention of peritendinous adhesions. Due to the ability of
PLGA in reduction of peritoneal adhesion bands and IB role
as an anti-inflammatory drug, in this study, we hypothesized
PLGA nanofibrous scaffolds containing IB might prevent
intra-abdominal adhesion formation, along with decreasing
inflammation at the site of injury. Actually, we decided to
evaluate the anti-inflammatory effect of IB on adhesion for-
mation by incorporating PLGA nanofibers in an abdominal
adhesion mice model.
In the present study, IB-incorporated PLGA was fabricated
using the electrospinning method, and after characterization,
their antiadhesion potential was compared to PLGA, IB and
control groups in a mice model.
Materials and Methods
Electrospun nanofiber fabrication
A PLGA (5 wt %) solution was prepared by dissolving
PLGA in chloroform/DMF (3/1 v/v) under constant stirring
for 2 h at room temperature. For preparation of the PLGA
solution containing IB, IB with a weight ratio of 10% w/w
referred to the PLGA were dissolved in 2 mL chloroform
and then added to a 4 wt % PLGA solution under constant
stirring for 4 h to obtain a uniform solution. IB-loaded nano-
fiber meshes were obtained by one-step two-nozzle electro-
spinning of PLGA/IB and PLGA solutions.
The electrospinning experimental setup was a Nano Model
(Tehran, Iran) with two nozzles. During electrospinning, pos-
itive 20 and 18 kV charges were applied at the tip of the
syringe needle for PLGA-IB and PLGA, respectively. The
PLGA and PLGA-IB mass flow rates were maintained at 0.5
and 0.4 mL/h, and the operating distances were selected at
20 and 15 cm, respectively. A rotary aluminum foil collector
with 300 rpm was used. Application of a voltage between
the needle and the collector forced the solution droplets to
leave the needle and spread on a cylinder in the form of
ultrafine fibers.17,18
Electrospun nanofiber characterization
Scanning Electron Microscopy. Fabricated PLGA and
PLGA-IB scaffolds were morphologically characterized by
using scanning electron microscopy (SEM, Philips XL30,
Netherlands).The samples were gold coated using a sputter
coater and then scanned by an SEM. The mean fiber diame-
ter was obtained by manual microstructure distance measure-
ment software, Nahamin Pardazan Asia.
Attenuated Total Reflection–Fourier Transform Infrared
Spectroscopy. Attenuated total reflection–Fourier transform
infrared (ATR-FTIR) analysis was used to evaluate and con-
firm the IB presence in composite scaffolds (PLGA-IB). The
spectra were recorded using an Equinox 55 spectrometer
(Bruker Optics, Germany) equipped with a DTGS (Deuter-
ated TriGlycine Sulfate) detector and a diamond ATR
crystal.
Mechanical properties. Mechanical behavior of nano-
fiber samples were characterized through tensile test on an
Instron universal testing machine (Model STM-20, SAN-
TAM, Iran), with sample sizes of 30 3 10 mm2 and a load-
ing velocity of 50 mm/min. The results are based on four
samples punched from a single electrospun sheet. The
machine recording data were used to plot the tensile stress–
strain curves.
Ibuprofen release behavior. PLGA-IB nanofibrous
meshes (weight 25 g) were immersed in 10 mL PBS then
incubated at 378C for 7 days with mild shaking (100 rpm).
At specified time intervals, 1 mL of release medium was col-
lected and replaced with 1 mL of fresh PBS. The amount of
IB in the released samples was determined by UV–vis spec-
troscopy at 264 nm. A standard calibration curve of IB in
the concentration range of 0–0.05 mg/mL (absorbance at
264 nm) was used to determine the IB concentration of
released samples. Triplicate specimens were investigated.
The accumulated IB released percent was calculated based
on the initial weight of IB incorporated in the electrospun
membranes. The results are presented in terms of cumulative
release, which was calculated according to the cumulative




The total mass of released IB, Ibj at Time j was calculated
from the mentioned equation, where Cj is the concentration
of released IB in the solution at Time j, V is the total volume
of release solution, and Vs is the sample volume.
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Surgical technique
In the present study, the surgical procedures for this inves-
tigation were performed in accordance with the Stem Cell
Technology Research Center (Tehran, Iran) guidelines.
Totally, 28 male NMRI mice (from Razi Institute, Karaj,
Iran) with weight ranging from 25 to 30 g were divided by
chance into four groups of seven as follow: Group 1, surgi-
cal abrasion without any treatment as control (n5 7); Group
2, surgical abrasion plus PLGA nanofibers (n5 7); Group 3,
surgical abrasion plus IB (n5 7); Group 4, surgical abrasion
plus composite scaffolds (PLGA-IB) (n5 7).
The animals were kept in cages (n5 7 in each) at a tem-
perature of a temperature of 216 28C and 12/12 h light/dark
conditions. The surgical treatment was performed under gen-
eral anesthesia induced by ether and ketamine (3 mg/kg) in
combination.
The adhesion induction model described by Hemadeh
et al.19 was used, which resulted in a 100% incidence of
adhesions in our control mice. Briefly, following anesthetic
induction, animals were placed in a supine position for shav-
ing and sterilization with alcohol and povidine iodine solu-
tions. A vertical midline incision of 2 cm was made in the
skin and the abdomen was opened. The exposed cecum was
then gently abraded using dry gauze pads at all surfaces until
it lost its shine, and hemorrhagic points became visible with-
out perforation. After that, the cecum was returned to its
anatomic position in the abdominal cavity. Before closing
the abdomen, 1.5 3 1.5 cm piece of each type of membrane
were sutured between the abdominal wall and peritoneum. In
the IB group, 1-mL IB solution 2 mg/mL was injected to the
abdomen. The abdominal wall was sutured in two layers.
After 1 week, mice were euthanized and their abdominal
cavities reopened evaluated by two other surgeons. The post-
surgical adhesion band was assessed based on previously
explained scales, based on two scales explained by Z€uhlke
et al. and Duran et al. as shown in Table 1.20,21
Microscopic examination
After sacrificing the animals, microscopic examination of
the morphology of the surgical location was performed to
look for signs of inflammation, infection and complications,
and images were captured.
Histologic evaluation
The nanofibers and the peritoneal tissues around them
were extracted following evaluation from the other tissues,
and then fixed in 10% formalin and immersed in paraffin.
Several paraffin sections were made by microtome and
stained by hematoxylin–eosin (HE). A semi quantitative
scoring system was used to evaluate the degree of inflamma-
tion, as indicated in Table 1.22
Biochemistry analysis. The mean cytokines such as inter-
leukin 1 (IL-1), interleukin 6 (IL-6) and tumor necrosis
factor-a (TNF-a) levels were determined by an ELISA
method at 0, 3, and 7 days after surgery. Peritoneal fluid
samples were collected in the ependorf tubes with 5%
EDTA and were centrifuged in 48C for 5 min in 3,000 rpm.
The supernatant was collected for ELISA assay using the
appropriate kits (Mouse IL-6, IL-1, TNF-a Platinum ELISA
kit/EBioscience Company). Each sample was distributed in
triplicate. Microsoft Excel was used for drawing standard
curves and ELISA results.
Statistical analysis
All variables were expressed as mean6 SD and ranks.
Differences between the adhesion and inflammation scores
were evaluated by Kruskal–Wallis variance analysis and
when significant (P< 0.05), the difference between specific
mean ranks was determined using the multiple comparison
procedure based on ranks.
Results
Scaffold characterization
Fabricated PLGA nanofibrous scaffolds showed a porous
structure, beads-free, uniform and smooth morphology with
an average diameter of 3006 500 nm (Figure 1a,b with low
magnification). It was also obvious that the morphology and
diameter of PLGA nanofibers was not significantly affected
by incorporating IB (Figure 1c,d).
PLGA mats showed a tensile strength of 2.726 0.94 MPa
and elongation at break of 49.806 5.84%. These properties
were improved significantly after IB incorporating (strength of
11.736 4.43 MPa and elongation at break of 76.636 21.53%)
which is due to the fact that crystalline IB added to amor-
phous PLGA, increase mechanical properties of IB-loaded
PLGA meshes compared to the PLGA ones. The release pro-
file of IB from IB-loaded PLGA nanofibrous scaffolds is
shown in Figure 2. The release mechanism is combined of
degradation and diffusion. Almost 30% of loaded IB released
within about 8 h without any initial burst release and then
50% of total IB has been released during only 4 h; same
release pattern has been reported by Pang et al.23 It is pre-
dicted that remained IB will release in the prolonged time.
Fourier Transform Infrared. FTIR spectroscopy is
widely employed for analyzing chemical components and
identifying characteristic groups. As shown in Figure 3, in
the FTIR spectrum of IB, the major peak at 1,750 cm21 was
attributed to the C5O stretching vibration and the major
Table 1. Adhesion and Inflammation Classifications
Grade Z€uuhlke et al. Duran et al. Inflammation
0 No adhesion No adhesion Nil
1 Filmy adhesions: gentle, blunt dissection required
to free adhesions
25% of area Giant cells, occasional scattered lymphocytes and
plasma cells
2 Mild adhesions: aggressive blunt dissection required
to free adhesions
25–50% of area Giant cells with increased numbers of admixed
lymphocytes, plasma cells, eosinophils,
neutrophils
3 Moderate adhesions: sharp dissection required to
free adhesions
50–100% of area Many admixed inflammatory cells, microabscesses
present
4 Severe adhesions: not dissectible without
damaging organs
– –
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band from 1,150 to 1,200 cm21 was assigned to the charac-
teristic vibrations of C–O stretch modes of the alcohols.
These characteristic peaks of IB can also be observed in the
FTIR spectrum of PLGA and PLGA-IB scaffolds. The spec-
trum of the PLGA-IB is more similar to that of the IB,
which confirms that IB was incorporated into the PLGA
scaffold.
The Grade of Adhesion Bands. No mortalities were
observed during or end of the study, abdominal adhesion
score was evaluated according to the Z€uhlke and Duran
et al. scaling that is shown in Figure 4. Significantly highest
decrease of adhesion score observed in animals were
implanted with PLGA-IB (P< 0.01), although animals
treated with PLGA also exhibited a decrease of adhesion
score in comparison to untreated control groups (P< 0.05).In
addition, the adhesion scores of animals treated with IB
alone did not significantly change in comparison to control
groups. Images that illustrate the grades of abdominal adhe-
sion are presented in Figures 5 and 6. Histological analysis
was performed to further explore the role of PLGA-IB in the
decrease of abdominal adhesion after surgery. The inflamma-
tion score of control group was dominant at the serosal sur-
face of the cecum. As showed in Figure 7, there were
inflammatory cells such as neutrophils, giant cells, plasma
Figure 1. SEM photograph of PLGA (A, B) and PLGA-IB (C, D) nanofibrous scaffolds in high and low magnification.
Figure 2. Release profile of IB from PLGA-IB nanofibrous
scaffold (n5 3).
Figure 3. FTIR spectra in the regions 1,150 to 1,200 and 1,700
to 1,800 cm21of IB, PLGA, and PLGA/IB.
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cells, and lymphocytes around the peritoneal surface. Statisti-
cally significant differences were observed between PLGA-
IB and PLGA groups with IB and control groups. Compared
with all groups, a significant decrease of inflammation scores
of mice following administration of PLGA-IB membrane
was revealed (P< 0.05). The inflammation scores in all
groups are shown in Figure 8.
Cytokine Assay. To determine the nature of the immune
responses we measured the amount of IL-1, IL-6, and TNF-a
produced in the supernatant at 0 and 3, 7 days after surgery.
As shown in Figures (9, 10), and 11, there are an increase in
IL-1, IL-6, and TNF-a after surgery compared to Day 0 but
the amount of IL-6 and TNF-a decrease significantly in
PLGA and PLGA-IB groups, the production level of IL-6
and TNF-a was significantly lower in PLGA-IB group than
the production level of these cytokines in other groups at 7
days after surgery.
According to Figure 9, IL-1 production was decreased in
all groups of mice after 7 days; however, a small decrease in
IL-1 occurred at 7 days postsurgery in PLGA-IB group com-
pared to other groups.
In conclusion, production of TNF-a and IL-6 were
decreased significantly in PLGA1 IB group compared with
another groups.
Discussion
Peritoneal adhesion commonly occurs after abdominal sur-
gery. It is necessary to mention that an adhesion is a band
between the cicatrix of surgery tissue and the peritoneal
membrane or gut which causes to stick together.6,15 This
untoward outcome is a challenge for surgeons and patients;
moreover, this problem also increases the cost of health care
after surgery. Recently, several biomaterials have been intro-
duced as a physical barrier to solve or at least reduce this
problem. For instance, B€olgen et al. incorporated an antibi-
otic in PCL and investigated its effect on rat abdominal
wounds after surgery in comparison with those of PCL and
control groups.24 Their macroscopically and histological
observations demonstrated that physical barriers could reduce
the value and hardness of postsurgery adhesion bands. They
also reported that there is a significant diminishing of adhe-
sion bands was detected when animals treat with antibiotic-
loaded PCL.24 Some researchers reported that implantation
of common biodegradable polymers such as poly(glycolic
acid) and poly(lactic acid) without antibiotic at the site of
surgery will cause severe inflammation due to the acidic
nature of the PCL.25,26 As IB suppresses inflammation, we
decided to load IB into PLGA and fabricate electrospun
nanofibers using this mixture.
Figure 4. Adhesion scores of each group using two scaling sys-
tems; the results are shown as mean6 SD. The sig-
nificant difference (P <0.05) has been shown
between the PLGA1 IB group with the control
group, there is not a significant difference between
IB group with control group.
Figure 5. Images show the intraperitoneal adhesion formation in mice according to Z€uhlke et al. (A) Grade 1, filmy adhesions: gentle,
blunt dissection required to free adhesions. (B) Grade 2, mild adhesions: aggressive blunt dissection required to free adhe-
sions. (C) Grade 3, moderate adhesions: sharp dissection required to free adhesions. (D and E) Grade 4, severe adhesions:
not dissectible without damaging organs.
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Antiadhesive band formation sutures of this construct
were investigated in a mouse abdominal adhesion model
and were compared with PLGA, IB, and control groups.
SEM images of PLGA-IB nanofibers confirmed that the
nanoscale and morphology were not significantly differ-
ent before and after IB incorporation. Electrospinning
has been used to load several drugs in nanofibrous scaf-
folds as drug carriers, these nanofibers playing a modula-
tor role in drug release. Our drug release analysis
demonstrated a growing and sustained trend of IB diffu-
sion from the PLGA nanofibers into the medium during
the 12-h assay.
Figure 6. Illustrations show the adhesion bands between peritoneum and abdominal wall in mice according to Duran et al. (A) Grade
0, no adhesion band. (B) Grade 1, 25% of area of membrane. (C) Grade 2, 25–50% of area of membrane. (D) Grade 3, 50–
100% of area of membrane.
Figure 7. Representative images of histological observations in two magnifications: for the control group (A) and (E); for the IB group
(B) and (F); for the PLGA group (C) and (G); for the PLGA1 IB group (D) and (H).
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The results of the animal adhesion model demonstrated
that both electrospun nanofibrous PLGA and IB-PLGA mats
had antiadhesive and anti-inflammatory properties and also
that these properties significantly improved after IB incorpo-
ration in PLGA. Anti-inflammatory effects of this construct
could be related to the efficient release of IB from PLGA
nanofibers on the one hand; on the other hand, these proper-
ties may result from the synergistic effects of PLGA as a
physical barrier and IB. These results are consistent with our
previously reported study where antiadhesive and anti-
inflammatory effects of PLLA, PCL, PES, and PLGA elec-
trospun nanofibers were evaluated in a mouse model com-
pared with the effects of oxidize-regenerated cellulose
(Interceed) as a positive control. The results showed that
PLGA had the lowest adhesion and inflammation scores
among mice treated with PES, PLGA, PLLA, PCL, and
Interceed and also among untreated mice.9 In another study,
antiadhesive and anti-inflammatory results of animals treated
with PLGA were inconsistent with our study; there was no
significant difference between the PLGA group and the
untreated group due to high hydrophobicity and shrinkage.
In our animal model, these properties were diminished by
suture mats according to the procedure reported by Dinar-
vand et al., and for hydrophobicity conformation water con-
tact angle was used, with the results demonstrating that
contact angle of PLGA (1128C) was not altered after incor-
poration with IB.9
To confirm lower inflammation as a result of the PLGA-
IB procedure, cytokines responsible for inflammation were
evaluated using ELISA. The rates of IL-1, IL-6, and TNF-a
in peritoneal fluid were found to be significantly decreased
in animals treated with PLGA-IB in comparison to other
groups. A mouse adhesion model was introduced for short-
time assay, and this model in rats was appropriate for long-
time assay. Inflammation is a phenomenon that occurs during
the primary steps in formation of the adhesion band. For this
reason, a week was selected as a time period for our study.
Conclusion
In this study, we have investigated the effect of PLGA-IB
mats in prevention of adhesion band that form after surgery.
Indeed, our results demonstrated that IB incorporated PLGA
mats have shown enhanced antiadhesive and anti-
inflammatory potentials in comparison to animals treated
with PLGA and untreated animals during the period of
study. This construct could be introduced as potentially can-
didate for physical barrier usage to prevention or diminish
abdominal postsurgery inflammation and adhesion band
formation.
Figure 8. Inflammation scores of each group; the data are
shown as mean 6SD. The significant difference
(P< 0.05) has been shown between the groups with
(*) and all other groups (**) and the control group.
Figure 9. The means cytokine (1L-1) level at Day 0 and at Day
3, 7 days after surgery. The results represent that
there is not a significant difference between groups.
Figure 10. The means cytokine (1L-6) level at Day 0 and at
Day 3, 7 days after surgery. The results represent
that at Day 3 and Day 7, there is a significant dif-
ference between PLGA1 IB group with another
groups.
Figure 11. The means cytokine (TNF_a) level at Day 0 and at
Day 3 7 days after surgery. The results represent
that, at Day 3 and Day 7, there is a significant dif-
ference between PLGA1 IB group with another
groups.
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